Pharma’s initial approach to adjusting to life post-COVID was to digitize its paper sales aids. That strategy has led to a flood of failed digital product launches, a study shows. Graphite’s Jon Hume and Nabriva Therapeutics’ Kimberly Coleman Clotman break down the findings.
MM+M Podcast 5.3.22: Why pharma’s “pivot to digital” resulted in a flood of failed digital product launches
Pharma's approach to life post-COVID was to digitize paper sales aids, which led to a flood of failed digital product launches. This week's guests discuss the findings.
